Biden Administration to Send 25 Million Doses of U.S. Vaccines Abroad
(Bloomberg) -- The U.S. government will send 25 million Covid-19 vaccine doses to countries across Asia, Africa and Latin America, the first time President Joe Biden's administration has shared shots it could have used at home.
Through the World Health Organization-backed Covax program, the U.S. plans to distribute an initial 6 million shots to Central and South America, 7 million to Asia including hard-hit India and 5 million to Africa, the White House said in a statement.
The U.S. will directly send another 6 million shots to places including Mexico, Canada, South Korea and the Palestinian territories, the White House said. Overall, the White House plans to send 75% of its total donated doses to the Covax program.
“As the days get brighter and brighter at home, we're focused on driving progress to help the pandemic around the globe,” White House Covid-19 response coordinator Jeff Zients said at a briefing Thursday.
The move is a watershed moment for the U.S., which secured the first hundreds of millions of doses made on its soil for domestic use but intends to be an engine of vaccine production globally. As vaccine demand wanes at home, Biden is facing calls internationally to release the U.S. stockpile of shots made by Pfizer Inc., Moderna Inc. and Johnson & Johnson in order to curb the rise of coronavirus variants.
The White House described Thursday's announcement as only the first tranche of a plan to begin supplying the world with vaccines.
Zients said the 25 million doses to be released first will be comprised of shots from Pfizer, Moderna and J&J. White House officials didn't specify breakdowns beyond that, or say whether particular countries will get a particular vaccine.
The Covax donations will go to dozens of countries across Central America, South America, Asia and Africa including Pakistan, Sri Lanka, Brazil and Argentina, along with India.
Recipients of the six million doses sent directly also will include Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan and Iraq, according to the White House. The U.S. will retain control of where the shots donated to Covax are ultimately distributed, National Security Adviser Jake Sullivan said in the briefing. Sullivan said India will receive doses directly as well as from Covax, giving it a supply from both channels.
The so-called Northern Triangle nations of Guatemala, El Salvador and Honduras will receive Covax doses, while Mexico will receive doses directly from the U.S. Vice President Kamala Harris will visit the region next week and called the leaders of Mexico, Guatemala and India about the vaccine distribution plan before Thursday's announcement, her office said.
Administration officials have consulted with vaccine manufacturers and international organizations on aspects of the operation, including transportation logistics and legal requirements, one person familiar with the plans said.
Thursday's announcement included a framework to distribute shots among countries based on need. Biden has said his administration will donate at least 80 million doses by the end of this month, though that included 60 million doses of AstraZeneca Plc's shot that are mired in a safety review and aren't yet available for use. The White House reiterated on Thursday that it would send at least 80 million vaccines abroad by the end of June.
The move is a sign of a cresting wave of American vaccine production poised to meet world demand. The gap between U.S. doses delivered and actually administered has risen to 70 million -- much of which are in various stages of distribution. But the figure is an indication of the U.S. glut Biden has to work with.
The ONE Campaign, an anti-poverty group, called the 25 million “a welcome step” but called on the U.S. to share its AstraZeneca doses and to lean on other wealthy nations to begin their own donations. “This is a once in a generation crisis, and as we approach the G7 next week, the world is looking to the US for global leadership and more ambition is needed,” the group's acting chief executive Tom Hart said in a statement.
In addition to the Biden administration's plans to begin sharing doses it bought, Pfizer and Moderna have both begun filling international orders from U.S. plants that previously supplied only the U.S. government.
Zients said the U.S. would also remove so-called priority ratings assigned under wartime powers to three other drugmakers: AstraZeneca, Sanofi and Novavax. That means suppliers won't have to give preference to U.S. orders from those companies.
Harris is set to meet with the leaders of Mexico and Guatemala next week on a trip through the region. Mexico and other countries have publicly asked the U.S. to share its vaccines, and some European allies had criticized Biden for hoarding U.S. production.
Next week, the president will leave for his first international trip, a series of stops in Europe including meetings of the Group of 7 nations, NATO and the European Union. A summit in Geneva with Russian President Vladimir Putin is also planned.
In the U.S., 297 million doses of vaccines have been administered so far. In the past week, an average of 1.1 million doses per day were administered, down significantly from just several weeks ago.
Biden has said he will not use U.S. vaccines as a diplomatic tool, after accusing China and Russia of leveraging doses of their vaccines for foreign policy gains.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.